Entero Healthcare Solutions Ltd. (ENTERO) - Total Liabilities
Based on the latest financial reports, Entero Healthcare Solutions Ltd. (ENTERO) has total liabilities worth Rs18.48 Billion INR (≈ $199.82 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Entero Healthcare Solutions Ltd. (ENTERO) asset resilience to evaluate the company's liquid asset resilience ratio.
Entero Healthcare Solutions Ltd. - Total Liabilities Trend (2019–2025)
This chart illustrates how Entero Healthcare Solutions Ltd.'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of Entero Healthcare Solutions Ltd..
Entero Healthcare Solutions Ltd. Competitors by Total Liabilities
The table below lists competitors of Entero Healthcare Solutions Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
SK Securities Co Ltd Preference Shares
KO:001515
|
Korea | ₩7.13 Trillion |
|
SILEX Systems Ltd
AU:SLX
|
Australia | AU$8.01 Million |
|
Xvivo Perfusion AB
ST:XVIVO
|
Sweden | Skr326.64 Million |
|
SP Group A/S
CO:SPG
|
Denmark | Dkr2.23 Billion |
|
Nuveen Select Tax-Free Income Portfolio
NYSE:NXP
|
USA | $44.19 Million |
|
Shenzhen Zhongzhuang Construction Group Co Ltd
SHE:002822
|
China | CN¥4.44 Billion |
|
GIGAVIS LTD (PROPOSED)
KQ:420770
|
Korea | ₩32.49 Billion |
|
TrustCo Bank Corp NY
NASDAQ:TRST
|
USA | $5.84 Billion |
Liability Composition Analysis (2019–2025)
This chart breaks down Entero Healthcare Solutions Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See ENTERO net asset quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.58 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.09 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Entero Healthcare Solutions Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Entero Healthcare Solutions Ltd. (2019–2025)
The table below shows the annual total liabilities of Entero Healthcare Solutions Ltd. from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | Rs18.48 Billion ≈ $199.82 Million |
+98.22% |
| 2024-09-30 | Rs9.32 Billion ≈ $100.81 Million |
+32.49% |
| 2023-09-30 | Rs7.04 Billion ≈ $76.09 Million |
-9.37% |
| 2022-09-30 | Rs7.76 Billion ≈ $83.96 Million |
+37.95% |
| 2021-09-30 | Rs5.63 Billion ≈ $60.86 Million |
+62.31% |
| 2020-09-30 | Rs3.47 Billion ≈ $37.50 Million |
+6.68% |
| 2019-09-30 | Rs3.25 Billion ≈ $35.15 Million |
-- |
About Entero Healthcare Solutions Ltd.
Entero Healthcare Solutions Limited engages in the distribution and marketing of pharmaceutical, surgical products and other allied services in India. The company involved in the distribution of generic formulations, active pharmaceutical ingredients, surgical consumables, rehabilitation products and devices, over the counter medical products, nutraceuticals, biosimilars, and biologics. It also p… Read more